[go: up one dir, main page]

FI924247L - En doseringsform foer frigoerande av medicin till tarmen - Google Patents

En doseringsform foer frigoerande av medicin till tarmen Download PDF

Info

Publication number
FI924247L
FI924247L FI924247A FI924247A FI924247L FI 924247 L FI924247 L FI 924247L FI 924247 A FI924247 A FI 924247A FI 924247 A FI924247 A FI 924247A FI 924247 L FI924247 L FI 924247L
Authority
FI
Finland
Prior art keywords
tarmen
frigoerande
doseringsform
medicin
foer
Prior art date
Application number
FI924247A
Other languages
English (en)
Other versions
FI924247A0 (fi
FI924247A7 (fi
Inventor
Jeremy C Wright
George V Guittard
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of FI924247A0 publication Critical patent/FI924247A0/fi
Publication of FI924247L publication Critical patent/FI924247L/fi
Publication of FI924247A7 publication Critical patent/FI924247A7/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Surgical Instruments (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI924247A 1990-03-23 1991-03-20 Annostusmuoto lääkkeen vapauttamiseksi suoleen FI924247A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/498,121 US5178866A (en) 1990-03-23 1990-03-23 Dosage form for delivering drug to the intestine
PCT/US1991/001850 WO1991014426A1 (en) 1990-03-23 1991-03-20 Dosage form for delivering drug to the intestine

Publications (3)

Publication Number Publication Date
FI924247A0 FI924247A0 (fi) 1992-09-22
FI924247L true FI924247L (fi) 1992-09-22
FI924247A7 FI924247A7 (fi) 1992-09-22

Family

ID=23979678

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924247A FI924247A7 (fi) 1990-03-23 1991-03-20 Annostusmuoto lääkkeen vapauttamiseksi suoleen

Country Status (18)

Country Link
US (2) US5178866A (fi)
EP (1) EP0521074B1 (fi)
JP (1) JP2963766B2 (fi)
KR (1) KR0169145B1 (fi)
AT (1) ATE102029T1 (fi)
AU (1) AU644645B2 (fi)
CA (1) CA2038672C (fi)
DE (1) DE69101314T2 (fi)
DK (1) DK0521074T3 (fi)
ES (1) ES2062779T3 (fi)
FI (1) FI924247A7 (fi)
IE (1) IE62393B1 (fi)
MX (1) MX173300B (fi)
NO (1) NO923590L (fi)
NZ (1) NZ237516A (fi)
PT (1) PT97086B (fi)
WO (1) WO1991014426A1 (fi)
ZA (1) ZA912069B (fi)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5681585A (en) * 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5223265A (en) * 1992-01-10 1993-06-29 Alza Corporation Osmotic device with delayed activation of drug delivery
US7070806B2 (en) * 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5248310A (en) * 1992-03-27 1993-09-28 Alza Corporation Oral osmotic device with hydrogel driving member
US5512299A (en) * 1992-03-30 1996-04-30 Alza Corporation Method of treating oral inflammatory disease
DK0661045T3 (da) * 1992-09-18 2002-10-28 Yamanouchi Pharma Co Ltd Hydrogelpræparat med forsinket frigivelse
US5358502A (en) * 1993-02-25 1994-10-25 Pfizer Inc PH-triggered osmotic bursting delivery devices
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
US5514663A (en) * 1993-10-19 1996-05-07 The Procter & Gamble Company Senna dosage form
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5849327A (en) * 1994-07-29 1998-12-15 Advanced Polymer Systems, Inc. Delivery of drugs to the lower gastrointestinal tract
FR2723536A1 (fr) * 1994-08-11 1996-02-16 Seth Pawan Composition permettant une liberation selective d'un principe actif
GB2292079B (en) * 1994-08-12 1998-07-15 Flexpharm Ltd Coated prednisolone preparation for the treatment of inflamatory bowel disease
US5736159A (en) * 1995-04-28 1998-04-07 Andrx Pharmaceuticals, Inc. Controlled release formulation for water insoluble drugs in which a passageway is formed in situ
JP4863534B2 (ja) * 1996-10-25 2012-01-25 スパーナス ファーマシューティカルズ インコーポレイテッド 可溶形態浸透用量送達システム
US6361796B1 (en) 1996-10-25 2002-03-26 Shire Laboratories, Inc. Soluble form osmotic dose delivery system
US6919373B1 (en) * 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
DE69834195T2 (de) 1997-07-02 2007-03-29 Euro-Celtique S.A. Stabilisierte tramadol formulierungen mit verzögerter freisetzung
DE19732903A1 (de) * 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
DK1154759T3 (da) 1998-12-30 2008-12-08 Dexcel Ltd Dispergerbart koncentrat til indgift af cyclosporin
US20040121014A1 (en) * 1999-03-22 2004-06-24 Control Delivery Systems, Inc. Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US6217895B1 (en) 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US6562375B1 (en) * 1999-08-04 2003-05-13 Yamanouchi Pharmaceuticals, Co., Ltd. Stable pharmaceutical composition for oral use
JP2003518487A (ja) 1999-12-23 2003-06-10 ファイザー・プロダクツ・インク ヒドロゲル駆動型積層薬物製剤
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano
US6669954B2 (en) 2000-01-25 2003-12-30 John R. Crison Controlled release of drugs
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
US20060034922A1 (en) * 2000-11-03 2006-02-16 Andrx Labs, Llc Controlled release metformin compositions
CA2427195C (en) 2000-11-03 2009-10-06 Andrx Corporation Controlled release metformin compositions
US6866866B1 (en) * 2000-11-03 2005-03-15 Andrx Labs, Llc Controlled release metformin compositions
US6790459B1 (en) 2000-11-03 2004-09-14 Andrx Labs, Llc Methods for treating diabetes via administration of controlled release metformin
US7491407B2 (en) * 2001-10-31 2009-02-17 North Carolina State University Fiber-based nano drug delivery systems (NDDS)
KR20040090961A (ko) * 2001-12-19 2004-10-27 알자 코포레이션 치료제의 조절된 방출을 위한 제제 및 투여 형태
US8871241B2 (en) 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
US20050208132A1 (en) * 2002-07-29 2005-09-22 Gayatri Sathyan Methods and dosage forms for reducing side effects of benzisozazole derivatives
US20050232995A1 (en) * 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
EP2604266A1 (en) 2002-09-20 2013-06-19 Andrx Labs Llc Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US20050051922A1 (en) * 2002-09-20 2005-03-10 Avinash Nangia Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
CA2508692C (en) * 2002-12-12 2012-04-03 Altana Pharma Ag Combination medicament
WO2005025544A1 (en) * 2003-09-11 2005-03-24 Glykon Technologies Group, Llc Enteric delivery of (-)-hydroxycitric acid
DE602004028497D1 (de) * 2003-09-15 2010-09-16 Nycomed Gmbh Verwendung von ciclesonid zur behandlung von entzündlichen darmerkrankungen
JP5618452B2 (ja) * 2003-09-16 2014-11-05 タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツングＴａｋｅｄａ ＧｍｂＨ 呼吸器疾患の治療のためのシクレソニドの使用
US20050181050A1 (en) * 2004-01-28 2005-08-18 Collegium Pharmaceutical, Inc. Dosage forms using drug-loaded ion exchange resins
AU2005235384B2 (en) * 2004-04-20 2010-09-09 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
US7588779B2 (en) * 2004-05-28 2009-09-15 Andrx Labs, Llc Pharmaceutical formulation containing a biguanide and an angiotensin antagonist
US20050287185A1 (en) * 2004-06-23 2005-12-29 David Wong Extended release oxybutynin formulation
US9011831B2 (en) * 2004-09-30 2015-04-21 Advanced Cardiovascular Systems, Inc. Methacrylate copolymers for medical devices
US7500679B2 (en) * 2004-10-08 2009-03-10 Wade James T Board for supporting front of snow vehicle
EP1846040A2 (en) * 2005-01-28 2007-10-24 Collegium Pharmaceutical, Inc. Non-ionic non-aqueous vehicles for topical and oral administration of carrier-complexed active agents
AU2006269944A1 (en) * 2005-07-19 2007-01-25 Inverseon, Inc. Improved pharmacokinetic profile of beta-adrenergic inverse agonists for the treatment of pulmonary airway diseases
US20070082084A1 (en) * 2005-10-07 2007-04-12 Catani Steven J Methods for weight management
US20070082115A1 (en) * 2005-10-07 2007-04-12 Aimutis William Ronald Jr Methods for inducing satiety, reducing food intake and reducing weight
US20070082085A1 (en) * 2005-10-07 2007-04-12 Catani Steven J Compositions and methods for reducing food intake and controlling weight
US20070082114A1 (en) * 2005-10-07 2007-04-12 Catani Steven J Methods for reducing weight
US20070082025A1 (en) * 2005-10-07 2007-04-12 Catani Steven J Methods for achieving and maintaining weight loss
US20070082026A1 (en) * 2005-10-07 2007-04-12 Aimutis William R Jr Compositions and methods for reducing food intake and controlling weight
US20070082030A1 (en) * 2005-10-07 2007-04-12 Aimutis William R Fiber satiety compositions
US20070082108A1 (en) * 2005-10-07 2007-04-12 Aimutis William R Jr Methods for reducing calorie intake
US20070082028A1 (en) * 2005-10-07 2007-04-12 Aimutis William R Jr Compositions and methods for inducing satiety and reducing caloric intake
US20070082029A1 (en) * 2005-10-07 2007-04-12 Aimutis William R Fiber satiety compositions
US20080085354A1 (en) * 2006-10-06 2008-04-10 Teresa Marie Paeschke Controlled hydration of hydrocolloids
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
US20090087484A1 (en) * 2007-09-28 2009-04-02 Alza Corporation Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
EP2334178A4 (en) * 2008-10-03 2012-04-11 Falk Pharma Gmbh COMPOSITIONS AND METHODS OF TREATING THERAPEUTIC DISEASES WITH GRANULATED MESALAMINE
CA2785468A1 (en) * 2009-12-23 2011-06-30 Psivida Us, Inc. Sustained release delivery devices
WO2012088304A2 (en) * 2010-12-22 2012-06-28 Psivida Us, Inc. Two-piece injectable drug delivery device with heat-cured seal
JP6203816B2 (ja) 2012-03-29 2017-09-27 セラバイオーム，エルエルシー 回腸及び虫垂に対して活性の胃腸部位特異的経口ワクチン接種製剤
CA3013541C (en) 2013-03-14 2021-01-19 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
CA2936748C (en) 2014-10-31 2017-08-08 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US20160256611A1 (en) * 2015-03-04 2016-09-08 Microvention, Inc. Drug Delivery Device
WO2018129061A1 (en) * 2017-01-05 2018-07-12 Cormedix Inc. Antimicrobial delivery system for the prevention and treatment of infections in the colon
US9707217B1 (en) 2017-02-03 2017-07-18 Osmotica Kereskedelmi Es Szolgaltato Kft Dose-dumping resistant controlled release dosage form
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
US11529310B2 (en) 2020-12-08 2022-12-20 Ruminant Biotech Corp Limited Devices and methods for delivery of substances to animals

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4036227A (en) * 1973-04-25 1977-07-19 Alza Corporation Osmotic releasing device having a plurality of release rate patterns
US4503030A (en) * 1983-06-06 1985-03-05 Alza Corporation Device for delivering drug to certain pH environments
US4717566A (en) * 1984-03-19 1988-01-05 Alza Corporation Dosage system and method of using same
US4627851A (en) * 1984-10-26 1986-12-09 Alza Corporation Colonic-therapeutic delivery system
US4904473A (en) * 1986-06-23 1990-02-27 International Minerals & Chemical Corp. Ruminant feed antacid containing potassium, sodium and chlorine
US4816262A (en) * 1986-08-28 1989-03-28 Universite De Montreal Controlled release tablet
US4810502A (en) * 1987-02-27 1989-03-07 Alza Corporation Pseudoephedrine brompheniramine therapy
US4904474A (en) * 1988-01-25 1990-02-27 Alza Corporation Delivery of drug to colon by oral disage form
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
GB8820353D0 (en) * 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet

Also Published As

Publication number Publication date
KR0169145B1 (ko) 1999-01-15
CA2038672A1 (en) 1991-09-24
PT97086A (pt) 1991-10-31
CA2038672C (en) 2002-01-15
WO1991014426A1 (en) 1991-10-03
EP0521074B1 (en) 1994-03-02
US5650170A (en) 1997-07-22
FI924247A0 (fi) 1992-09-22
AU7581391A (en) 1991-10-21
ZA912069B (en) 1991-12-24
NZ237516A (en) 1993-04-28
ATE102029T1 (de) 1994-03-15
DE69101314D1 (de) 1994-04-07
PT97086B (pt) 1998-08-31
DE69101314T2 (de) 1994-06-09
DK0521074T3 (da) 1994-05-09
JP2963766B2 (ja) 1999-10-18
ES2062779T3 (es) 1994-12-16
FI924247A7 (fi) 1992-09-22
NO923590L (no) 1992-11-23
US5178866A (en) 1993-01-12
EP0521074A1 (en) 1993-01-07
IE62393B1 (en) 1995-01-25
KR930700074A (ko) 1993-03-13
NO923590D0 (no) 1992-09-16
AU644645B2 (en) 1993-12-16
JPH05506022A (ja) 1993-09-02
IE910919A1 (en) 1991-09-25
MX173300B (es) 1994-02-14

Similar Documents

Publication Publication Date Title
FI924247L (fi) En doseringsform foer frigoerande av medicin till tarmen
FI930862L (fi) En doseringsform foer tidsvarierande moenster av laekemedeloeverlaotelse
FI930886A0 (fi) Foerfarande foer hindrande av avstoetning av transplanterad vaevnad
FI930848A0 (fi) Foerfarande foer separering av ilmenit
FI923931L (fi) Anordning foer granskning av insidan av en foergrenad roerlinje
FI930736L (fi) Foerfarande foer framstaellning av ramnos fraon ramnolipider
FI930763A7 (fi) Framstaellning av klordioxid fraon klorsyra
FI925884A7 (fi) Avlaegsning av signaldistorsion
FI930165A0 (fi) Framstaellning av synnerligen aktiva tvaettmedelspartiklar
FI924569L (fi) Foerfarande foer enantioselektiv framstaellning av fenylisoserinderivat
FI924568L (fi) Foerfarande foer stereoselektiv framstaellning av fenylisoserinderivat
FI931355A0 (fi) Fasoeverfoeringsmedierat foerfarande foer framstaellning av glukamidtvaettmedel
FI930552L (fi) Nytt foerfarande foer framstaellning av nukleotider
FI925415L (fi) Framstaellning av substituerade piperidiner
FI925988L (fi) Foerfarande foer framstaellning av b-laktamer
FI925515L (fi) Foerfarande foer framstaellning av alfa-2-interferonkristaller
FI925435A7 (fi) Foerfarande foer beredning av en vattenloesning av natriumfoereningar
FI931354L (fi) Hoegkatalytiskt foerfarande foer framstaellning av glukamidtvaettmedel
FI924436A7 (fi) Foerfarande foer tillverkning av expanderade polystyrenfolier
FI925805A0 (fi) Framstaellning av kompositmaterial
FI924826L (fi) Fettkompositioner innehaollande polyestrar av polyolfettsyror
FI925609A0 (fi) Foerfarande foer framstaellning av sykliska sulfater
FI924374L (fi) Foerfarande foer dubbelsidig belaeggning av en roerlig materialbana
FI924371L (fi) Foerfarande foer tillverkning av en elektromagnetisk omvandlare
FI923776A7 (fi) Foerfarande foer formning av pappersark

Legal Events

Date Code Title Description
FD Application lapsed